Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
2.04 NOK | +1.49% | -1.92% | -22.14% |
May. 16 | Hofseth BioCare ASA Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 14 | Hofseth BioCare ASA Announces Board Changes | CI |
Business Summary
Number of employees: 70
Sales per Business
NOK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Salmon Oil (OmeGo)
59.3
%
| 78 | 64.6 % | 129 | 59.3 % | +66.50% |
Non-soluble Protein (PetGo)
15.2
%
| 25 | 21.2 % | 33 | 15.2 % | +30.51% |
Reconciling Items
12.3
%
| - | - | 27 | 12.3 % | - |
Soluble Protein Hydrolysate (ProGo)
10.9
%
| 13 | 10.5 % | 24 | 10.9 % | +89.72% |
Calcium (CalGo)
1.2
%
| 3 | 2.4 % | 3 | 1.2 % | -10.67% |
Other
1.1
%
| 2 | 1.4 % | 2 | 1.1 % | +40.66% |
Sales per region
NOK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
24.3
%
| - | - | 47 | 24.3 % | - |
France
21.1
%
| - | - | 40 | 21.1 % | - |
Belgium
13.8
%
| - | - | 26 | 13.8 % | - |
Europe excluding Norway, United Kingdom, France, Belgium
13.1
%
| 78 | 64.9 % | 25 | 13.1 % | -67.95% |
United Kingdom
10.4
%
| - | - | 20 | 10.4 % | - |
Japan
9.6
%
| - | - | 18 | 9.6 % | - |
Norway
4.7
%
| 7 | 5.8 % | 9 | 4.7 % | +30.11% |
Asia excluding Japan
3.0
%
| 14 | 11.8 % | 6 | 3.0 % | -59.23% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jon Olav Ødegård
CEO | Chief Executive Officer | 51 | 13-02-28 |
Roger Hofseth
CEO | Chief Executive Officer | 50 | 99-12-31 |
Crawford Currie
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | 63 | 09-12-31 | |
James Berger
IRC | Investor Relations Contact | - | - |
Andy Gill
PRN | Corporate Officer/Principal | - | 20-12-31 |
Kai Morten Thuen
SAM | Sales & Marketing | - | 14-08-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Roger Hofseth
CEO | Chief Executive Officer | 50 | 99-12-31 |
Director/Board Member | 53 | 15-04-30 | |
Director/Board Member | 49 | 15-04-30 | |
Amy Novogratz
BRD | Director/Board Member | - | 21-12-02 |
Crawford Currie
CTO | Chief Tech/Sci/R&D Officer | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 395,081,030 | 165,069,381 ( 41.78 %) | 0 | 41.78 % |
Company contact information
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-22.14% | 74.2M | |
-1.10% | 287B | |
-6.38% | 90.96B | |
-7.00% | 41.76B | |
+1.12% | 41.74B | |
+5.16% | 39.65B | |
+3.56% | 38.08B | |
-15.16% | 30.29B | |
-4.01% | 28.91B | |
+7.73% | 24.27B |
- Stock Market
- Equities
- HBC Stock
- Company Hofseth BioCare ASA